Genomic testing in cancer: NTRK testing and reporting pathways

Resource Type: Presentation, Resource, Video

In this presentation, Dr Mike Hubank, Scientific Director of the North Thames GLH provides an overview of the clinical testing and reporting pathways associated with managing cancer patients with NTRK gene-fusions.

Recorded in June 2021 as part of The Genomic Medicine Service and NTRK Tumour Agnostic Testing and Treatment Pathways in Solid Tumours virtual meeting. You can view the other presentations from the meeting by following the links below;